These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A new ubiquitin ligase involved in p57KIP2 proteolysis regulates osteoblast cell differentiation. Kim M; Nakamoto T; Nishimori S; Tanaka K; Chiba T EMBO Rep; 2008 Sep; 9(9):878-84. PubMed ID: 18660753 [TBL] [Abstract][Full Text] [Related]
3. p57(Kip2) is degraded through the proteasome in osteoblasts stimulated to proliferation by transforming growth factor beta1. Urano T; Yashiroda H; Muraoka M; Tanaka K; Hosoi T; Inoue S; Ouchi Y; Toyoshima H J Biol Chem; 1999 Apr; 274(18):12197-200. PubMed ID: 10212182 [TBL] [Abstract][Full Text] [Related]
4. The cell cycle-regulated B-Myb transcription factor overcomes cyclin-dependent kinase inhibitory activity of p57(KIP2) by interacting with its cyclin-binding domain. Joaquin M; Watson RJ J Biol Chem; 2003 Nov; 278(45):44255-64. PubMed ID: 12947099 [TBL] [Abstract][Full Text] [Related]
5. Periodic expression of the cyclin-dependent kinase inhibitor p57(Kip2) in trophoblast giant cells defines a G2-like gap phase of the endocycle. Hattori N; Davies TC; Anson-Cartwright L; Cross JC Mol Biol Cell; 2000 Mar; 11(3):1037-45. PubMed ID: 10712518 [TBL] [Abstract][Full Text] [Related]
6. The cyclin kinase inhibitor p57kip2 regulates TGF-beta-induced compensatory tubular hypertrophy: effect of the immunomodulator AS101. Sinuani I; Weissgarten J; Beberashvili I; Rapoport MJ; Sandbank J; Feldman L; Albeck M; Averbukh Z; Sredni B Nephrol Dial Transplant; 2009 Aug; 24(8):2328-38. PubMed ID: 19321762 [TBL] [Abstract][Full Text] [Related]
7. The cyclin-dependent kinase inhibitor p57Kip2 regulates cell cycle exit, differentiation, and migration of embryonic cerebral cortical precursors. Tury A; Mairet-Coello G; DiCicco-Bloom E Cereb Cortex; 2011 Aug; 21(8):1840-56. PubMed ID: 21245411 [TBL] [Abstract][Full Text] [Related]
8. Identification of multiple cell cycle regulatory functions of p57Kip2 in human T lymphocytes. Li G; Domenico J; Lucas JJ; Gelfand EW J Immunol; 2004 Aug; 173(4):2383-91. PubMed ID: 15294951 [TBL] [Abstract][Full Text] [Related]
9. Possible involvement of the p57(Kip2) gene in bone metabolism. Urano T; Hosoi T; Shiraki M; Toyoshima H; Ouchi Y; Inoue S Biochem Biophys Res Commun; 2000 Mar; 269(2):422-6. PubMed ID: 10708569 [TBL] [Abstract][Full Text] [Related]
10. Bmi-1 extends the life span of normal human oral keratinocytes by inhibiting the TGF-beta signaling. Kim RH; Lieberman MB; Lee R; Shin KH; Mehrazarin S; Oh JE; Park NH; Kang MK Exp Cell Res; 2010 Oct; 316(16):2600-8. PubMed ID: 20630502 [TBL] [Abstract][Full Text] [Related]
11. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells. Poncelet AC; de Caestecker MP; Schnaper HW Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488 [TBL] [Abstract][Full Text] [Related]
12. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling. Fanayan S; Firth SM; Baxter RC J Biol Chem; 2002 Mar; 277(9):7255-61. PubMed ID: 11751851 [TBL] [Abstract][Full Text] [Related]
13. Signal-induced ubiquitination of p57(Kip2) is independent of the C-terminal consensus Cdk phosphorylation site. Leibovitch MP; Kannengiesser C; Leibovitch SA FEBS Lett; 2003 May; 543(1-3):125-8. PubMed ID: 12753918 [TBL] [Abstract][Full Text] [Related]
14. p57(Kip2) regulates progenitor cell proliferation and amacrine interneuron development in the mouse retina. Dyer MA; Cepko CL Development; 2000 Aug; 127(16):3593-605. PubMed ID: 10903183 [TBL] [Abstract][Full Text] [Related]
15. TGF-beta1-mediated hypertrophy involves inhibiting pRB phosphorylation by blocking activation of cyclin E kinase. Liu B; Preisig P Am J Physiol; 1999 Aug; 277(2):F186-94. PubMed ID: 10444572 [TBL] [Abstract][Full Text] [Related]
16. Green tea polyphenol-induced epidermal keratinocyte differentiation is associated with coordinated expression of p57/KIP2 and caspase 14. Hsu S; Yamamoto T; Borke J; Walsh DS; Singh B; Rao S; Takaaki K; Nah-Do N; Lapp C; Lapp D; Foster E; Bollag WB; Lewis J; Wataha J; Osaki T; Schuster G J Pharmacol Exp Ther; 2005 Mar; 312(3):884-90. PubMed ID: 15537824 [TBL] [Abstract][Full Text] [Related]
17. P21-activated kinase 4 regulates the cyclin-dependent kinase inhibitor p57(kip2) in human breast cancer. Li Y; Wang D; Zhang H; Wang C; Dai W; Cheng Z; Wang G; Li F Anat Rec (Hoboken); 2013 Oct; 296(10):1561-7. PubMed ID: 23873832 [TBL] [Abstract][Full Text] [Related]
18. Downregulation of cyclin-dependent kinase inhibitor; p57(kip2), is involved in the cell cycle progression of vascular smooth muscle cells. Nakano N; Urasawa K; Takagi Y; Saito T; Kaneta S; Ishikawa S; Higashi H; Tsutsui H; Hatakeyama M; Kitabatake A Biochem Biophys Res Commun; 2005 Dec; 338(3):1661-7. PubMed ID: 16259944 [TBL] [Abstract][Full Text] [Related]
19. Targeted inhibition of p57 and p15 blocks transforming growth factor beta-inhibited proliferation of primary cultured human limbal epithelial cells. Chen Z; Li DQ; Tong L; Stewart P; Chu C; Pflugfelder SC Mol Vis; 2006 Aug; 12():983-94. PubMed ID: 16943770 [TBL] [Abstract][Full Text] [Related]